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Introduction
The incidence of  primary cardiac tumors is between 
0.0017% and 0.019%, with 25% of  them being malignant 
(1-3). These tumors have a poor prognosis due to their di-
agnosis at an advanced stage, due to nonspecific symptoms 
and insufficient awareness about these lesions (4). Echocar-
diography, CT, and MRI are the primary diagnostic mo-
dalities, followed by tissue biopsy. 
Case report 
A 46-year-old African-American female presented to her 
primary care physician with worsening shortness of  breath 
and palpitations of  a few weeks' duration. Her past medical 
history was significant for right breast cancer, and she was 
status postmodified radical mastectomy with negative mar-
gins and negative lymph nodes. She was initially treated 
with azithromycin and a tapering dose of  steroids. Her 
condition did not improve, and she then presented to the 
emergency department with worsening shortness of  breath. 
On admission, the patient was afebrile with mild sinus 
tachycardia and elevated blood pressure. On clinical ex-
amination, she had bilateral lower-extremity edema with 
no jugular venous distension and no rales on chest auscul-
tation. A complete blood count showed leucocytosis, 
mainly neutrophilic with a microcytic anemia. Blood chem-
istry revealed normal renal function with mildly elevated 
liver-function tests, namely aspartate aminotransferase at 
84U/L (reference level 10-31U/L) and alanine amino-
transferase at 78U/L (reference level 10-41U/L). Cardiac 
biomarkers showed elevated serum troponin I at 
0.20ng/mL (reference level<0.10ng/mL) and brain natriu-
retic peptide at 805pg/mL (reference level<100pg/mL). 
Chest radiography showed mild cardiomegaly, with no 
focal consolidation or pleural effusion. The patient was 
treated with intravenous diuretics, and her symptoms im-
proved with diuresis. Computed tomography angiography 
(CTA) of  the chest was performed due to elevated d-dimer 
at 1.22mg/L (reference level<0.59mg/L). It showed no 
evidence of  acute pulmonary thrombo-embolic disease but 
showed masslike low density along the anterolateral left 
ventricular walls at the mid and apical levels (Fig. 1). Dif-
ferential considerations at that time included a thrombus, 
asymmetric hypertrophic cardiomyopathy, and a cardiac 
neoplasm. Transthoracic echocardiography showed an 
ejection fraction of  25-30%, with global hypokinesis of  the 
left ventricle (Fig. 2). A large isoechoic mass was seen along 
the anterior to anteroseptal wall. There was mild systolic 
mitral regurgitation and moderate-to-severe tricuspid re-
gurgitation. The right ventricular systolic pressure was 66 
mmHg. Cardiac MRI was performed to further evaluate 
for a left-ventricular mass versus thrombus. It showed a 
large heterogeneneous mass (Fig. 3) involving the anterior 
wall of  the left ventricle from the base to apex and extend-
ing into the portions of  the anterolateral and anteroseptal 
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walls. The mass was heterogeneous in signal intensity, with 
peripheral enhancement on the delayed images. Central 
areas of  nonenhancement were seen, likely due to necrosis. 
LV was mildly dilated, with severe hypokinesis/akinesis of  
the basal to apical anterior wall. The estimated LVEF was 
45-50%.
The cardiothoracic surgery unit recommended a PET-
CT, which revealed hypermetabolic activity along the ante-
rior and anterolateral wall of  the left ventricle correspond-
ing to the location of  the mass seen on CT. Differential 
considerations included metastatic breast carcinoma and 
sarcoma. The patient subsequently underwent a left ante-
rior thoracotomy. Intraoperatively, the mass on the anterior 
lateral surface of  the left ventricle was identified, which was 
Spindle-cell sarcoma of the heart: A rare cause for a cardiac mass 
RCR Radiology Case Reports | radiology.casereports.net! 2! 2012 | Volume 7 | Issue 4
Figure 1. 46-year-old female with spindle-cell sarcoma of 
the heart. Axial CT angiography image showed a large 
mass (asterisk) in the region of the left ventricle. Incidentally 
noted were also a small right pleural effusion and a right 
breast implant.
Figure 2. 46-year-old female with spindle-cell sarcoma of 
the heart. Parasternal long-axis (A) and short-axis (B) 
views showed an echogenic mass in the left ventricular 
lumen (asterisk) and thickening of the left ventricular wall. 
Figure 3. 46-year-old female with spindle-cell sarcoma of the heart. Short-axis (A) and 4-chamber (B) bright-blood MRI images 
showed a mass in the left ventricle with predominantly hyperintense T2 signal. A fat-suppressed, postcontrast, T1-weighted, 
short-axis image (C) showed heterogeneous enhancement in the mass lesion.
lateral to the left anterior descending artery and superior 
from the apex. Neovascularity was noted on the surface of  
the mass. The location of  the mass was confirmed by pal-
pation on transesophageal echocardiography. The first set 
of  specimens was sent for frozen section, the result of  
which was consistent with carcinoma with spindle-cell ele-
ments. After the frozen section, two additional core needle 
biopsies were taken. Postoperatively, the patient developed 
hypotension and acute kidney injury, for which she required 
vasopressor support and intravenous fluids. She improved 
gradually and was weaned off  vasopressor support. Diu-
retic therapy resumed. Pericardial fluid cytology and cell 
block yielded reactive mesothelial cells and macrophages. 
Cells diagnostic of  malignancy were not identified. A left-
ventricular-mass core biopsy (Fig. 4) was performed. The 
tumor had a Ki-67 proliferative index of  80%. Tumor cells 
were negative for AE1/3, actin, desmin, ALK-1, HMB-45, 
CD31, CD34, and S-100. A preliminary diagnosis of  un-
classified, high-grade, spindle-cell sarcoma was made. Due 
to a large tumor burden, our patient was considered inop-
erable and is currently receiving chemotherapy. After che-
motherapy, her surgical options will be re-evaluated.
Discussion
Transthoracic echocardiography (TTE) is the primary 
imaging modality for the initial diagnosis of  intracardiac 
masses. TTE is noninvasive and inexpensive, and it pro-
vides functional information in addition to morphological 
details in multiple planes. However, its effectiveness can be 
limited by patient habitus and operator experience. Transe-
sophageal echocardiography (TEE) provides better resolu-
tion, as it allows for use of  higher-frequency transducers. 
However, besides being an invasive procedure, TEE also 
provides limited soft-tissue characterization and visualiza-
tion of  the mediastinum. Imaging with CT overcomes 
some of  the limitations of  echocardiography and provides 
superior soft-tissue contrast, with improved detection of  fat 
and calcification. Cardiac MRI (CMRI) has even better 
soft-tissue characterization than CT and echocardiography, 
and allows functional assessment. CMRI is useful in the 
depiction of  extracardiac involvement and intrinsic myo-
cardial disease. The limitations of  CMRI include cost and 
dependence on regular electrocardiographic rhythms and 
cardiac gating (5).
Metastatic cardiac tumors outnumber primary cardiac 
tumors by 20-40 times. The most common primary cardiac 
tumor is angiosarcoma, which tends to involve the pericar-
dium and occurs most often in the right atrium. Rhabdo-
myosarcoma is the most common primary cardiac malig-
nancy in children and tends to favor involvement of  the 
valves. Undifferentiated sarcomas are most commonly seen 
to occur in the left atrium. Some of  the other pathological 
types include fibrosarcoma, primary osteogenic cardiac 
sarcoma, leiomyosarcoma, liposarcoma, and primary car-
diac lymphomas. Primary cardiac lymphomas are seen 
most commonly in immunocompromised individuals and 
may respond to chemotherapy. Leiomyosarcoma, primary 
osteogenic cardiac sarcoma, and fibrosarcoma tend to favor 
the left atrium. Liposarcomas often present as large infil-
trating masses, while osteogenic sarcomas may be distin-
guished by the frequent presence of  calcification. Advances 
in imaging technology now allow for earlier detection of  
these rare malignancies (5).
Wide surgical resection is the cornerstone for therapy for 
cardiac sarcomas. Some cardiac tumors are sensitive to 
radiation and chemotherapy. Cardiac transplantation is 
sometimes considered for eligible patients with inoperable 
sarcomas. Park JH et al (6) have described a 59-year-old 
female who initially presented with chest pain and had 
coronary angiography, revealing critical stenosis of  the left 
main coronary artery ostium. Subsequent echocardiogra-
phy showed pericardial effusion; after that, coronary mul-
tidetector computed tomography (MDCT) angiography 
showed a cardiac mass compressing the left main coronary 
artery ostium. The patient was treated with radical surgical 
excision of  the tumor mass. Microscopic examination of  
the tumor revealed spindle cells exhibiting nonspecific dif-
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Figure 4. 46-year-old female with spindle-cell sarcoma of 
the heart. Low-power 4x (A) and high-power 40x (B) im-
ages. On pathology, highly cellular spindle-cell proliferation 
in a fascicular growth pattern was noted, along with 
hemangiopericytoma-like vasculature ("staghorn” configura-
tion) surrounded by spindle cells. The cells had a scant 
amount of acidophilic cytoplasm, and the nuclei were cigar-
shaped or blunt-ended and curved with variable atypia. 
Mitotic figures were common (6-10 per high-power field), 
and atypical mitosis was also seen. 
ferentiation. Mayer F et al (7) described a series of  14 pa-
tients with sarcomas arising from the heart or the great 
vessels. One of  the patients had a polymorphic spindle-cell 
sarcoma, which responded very well to complete resection 
and palliative chemotherapy with Doxorubicin and Ofos-
famide. This patient had no evidence of  disease at 156 
months of  followup. The median survival among patient in 
this case series was 17 months. Certain histological types, 
like Ewing’s sarcoma and potential embryonal rhabdomyo-
sarcoma (PNET), were more responsive to chemotherapy. 
Even if  curative resection is not achievable, surgical debulk-
ing may provide hemodynamic relief. 
Although we have made considerable advances in imag-
ing techniques, early detection of  cardiac sarcomas is lim-
ited by lack of  early symptoms and subsequent delay in 
patient presentation. Prognosis depends on the histopathol-
ogy as well as the location and extent of  the specific 
tumors.
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